Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The nephritogenic immune response

M M Fitzsimons1, M H Foster

  • 1University of Pennsylvania School of Medicine, Philadelphia, USA.

Current Opinion in Nephrology and Hypertension
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro and in vivo expression of a nephritogenic Ig heavy chain determinant: pathogenic autoreactivity requires permissive light chains.

Immunology and cell biology·2001
Same author

Chronic salicylism resulting in noncardiogenic pulmonary edema requiring hemodialysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2000
Same author

Diverse endogenous light chains contribute to basement membrane reactivity in nonautoimmune mice transgenic for an anti-laminin Ig heavy chain.

Immunogenetics·2000
Same author

Membranoproliferative glomerulonephritis type I, mixed cryoglobulinemia and lymphoma in the absence of hepatitis C infection.

American journal of nephrology·1999
Same author

Lupus nephritis: update on pathogenesis and disease mechanisms.

Seminars in nephrology·1999
Same author

Antiidiotypic antibody recognizes an amiloride binding domain within the alpha subunit of the epithelial Na+ channel.

The Journal of biological chemistry·1999
Same journal

Updates in management of cardiorenal syndrome.

Current opinion in nephrology and hypertension·2026
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
See all related articles

Understanding nephritogenic immune responses is key to treating autoimmune kidney diseases. Research identifies renal antigens and novel pathways for immune-mediated tissue injury, offering new therapeutic targets.

Area of Science:

  • Immunology
  • Nephrology
  • Autoimmunity

Background:

  • Nephritogenic immune responses are studied using experimental models of autoimmunity.
  • Genetic and gene ablation studies reveal multiple mechanisms of disease susceptibility.
  • Identifying renal antigens recognized by nephritogenic lymphocytes is crucial for understanding disease.

Purpose of the Study:

  • To advance the understanding of the etiopathogenesis of nephritogenic immune responses.
  • To characterize effector mechanisms in immune-mediated renal injury.
  • To explore novel therapeutic interventions for immunologic renal injury.

Main Methods:

  • Utilizing experimental models of systemic and organ-specific autoimmunity.
  • Conducting genetic analyses and immune-related gene ablation studies.

Related Experiment Videos

  • Performing epitope mapping of glomerular antigens and identifying novel injury pathways.

    • Main Results:

    • Multiple independent mechanisms contribute to disease susceptibility.
    • Novel pathways in glomerular-tubulointerstitial communication and fibrosis identified.
    • Successful interruption of signal transduction and TGF-β1 blockade demonstrated.

    Conclusions:

    • Further characterization of renal antigens is needed.
    • Novel pathways of immune-mediated tissue injury offer therapeutic targets.
    • Gene therapy and pathway blockade show promise for treating immunologic renal injury.